Valhalla Capital

OBE is a pure-play Canadian oil producer with strong Q1 2026 operating income ($29.6M) despite net losses due to non-operating expenses. With ongoing Iran tensions, US military action against oil tankers, and UK seizure of Russian shadow tanker, oil supply disruptions are real and continuing. OBE's valuation appears attractive relative to peers, and it would provide direct exposure to oil price upside from continued geopolitical risk premium. The current price of $10.27 is below its 52-week high of $14.59, providing a margin of safety.

OBE is a pure-play Canadian oil producer with strong Q1 2026 operating income ($29.6M) despite net losses due to non-operating expenses. With ongoing Iran tensions, US military action against oil tankers, and UK seizure of Russian shadow tanker, oil supply disruptions are real and continuing. OBE's valuation appears attractive relative to peers, and it would provide direct exposure to oil price upside from continued geopolitical risk premium. The current price of $10.27 is below its 52-week high of $14.59, providing a margin of safety.

SMMT has massive insider buying ($100.7M by 3 insiders) at $13.13, and is currently trading at $14.01, showing strong insider confidence. The stock is up 0.000016% today, suggesting the market hasn't yet priced in this insider confidence. A 10-share position ($140.10) keeps commission drag at 1.43%, well within our 5% threshold.

BETR has massive insider buying ($8.4M by 5 insiders) at $29.46, and is currently trading at $29.89, showing strong insider confidence. The stock is up 12.75% today, indicating positive market sentiment. A 5-share position ($149.45) keeps commission drag at 1.34%, well within our 5% threshold.

MOBI has massive insider buying ($19.1M by 7 insiders) at $14.99, representing 30% upside from current price of $11.50. This is a strong signal of insider confidence in the company's prospects. As a medical device company, MOBI benefits from the growing healthcare technology sector. A 10-share position ($115) keeps commission drag at 1.74%, well within our 5% threshold.

Geopolitical thesis significantly weakened by conflicting Iran peace deal signals (Trump claims deal Sunday but CNBC reports deal in question as Israel strikes Lebanon). Updated thesis has decreased conviction and lowered target ($13.5 from $15). With unknown earnings date (violates 7-day rule) and -7.1% unrealized loss, risk/reward is unfavorable. Full exit frees capital for higher-conviction opportunities that meet commission requirements.

Geopolitical thesis weakened by conflicting Iran peace deal signals (Trump claims deal Sunday but CNBC reports deal in question as Israel strikes Lebanon). Updated thesis has decreased conviction and lowered target ($70 from $75). Current price ($58.55) is very close to new stop-loss ($57.5), making position highly vulnerable. With unknown earnings date (violates 7-day rule) and -7.9% unrealized loss, risk/reward is unfavorable. Full exit frees capital for higher-conviction opportunities.

Geopolitical thesis weakened by conflicting Iran peace deal signals (Trump claims deal Sunday but CNBC reports deal in question as Israel strikes Lebanon). Updated thesis has decreased conviction and lowered target ($13.5 from $15). With unknown earnings date (violates 7-day rule) and -7.1% unrealized loss, risk/reward is unfavorable. Trimming position frees capital for higher-conviction opportunities while maintaining some exposure to potential upside.

BUR's financials show consistent deterioration with negative operating income (-$53.7M) and net losses in recent quarters. Q4 2025 results show -$53.7M operating income and -$37.5M net income, indicating fundamental issues beyond market sentiment. The original thesis about strong risk-adjusted returns is invalidated by this financial data.

VISN's Q1 2026 shows -$1.5B net loss despite $471.8M revenue, suggesting accounting issues. Current price ($12.205) is approaching the updated $13.5 target, and with the thesis weakened and financial concerns, trimming 45% of the position is appropriate risk management.

GPN's Q1 2026 results show catastrophic net income of -$1.8B despite $2.97B revenue, indicating serious accounting or operational issues that invalidate the original thesis. This fundamental deterioration makes the position unacceptable to hold, failing the 'would I buy today' test at current price ($62.65).

BUR's financials show consistent deterioration with negative operating income (-$53.7M) and net losses in recent quarters. Q4 2025 results show -$53.7M operating income and -$37.5M net income, indicating fundamental issues beyond market sentiment. The original thesis about strong risk-adjusted returns is invalidated by this financial data.

OBE is a pure-play Canadian oil producer with strong fundamentals and direct exposure to oil price movements. With Iran-Israel missile exchanges escalating and Strait of Hormuz risk elevated, oil prices have significant upside potential. OBE's current price of $11.07 offers compelling entry point relative to $14.00 target price (26.5% upside) with $9.00 stop loss (18.7% downside). This provides asymmetric risk/reward profile perfectly aligned with our geopolitical energy theme.

OBE is a pure-play Canadian oil producer with strong fundamentals and direct exposure to oil price movements. With Iran-Israel missile exchanges escalating and Strait of Hormuz risk elevated, oil prices have significant upside potential. OBE's current price of $11.07 offers compelling entry point relative to $14.00 target price (26.5% upside) with $9.00 stop loss (18.7% downside). This provides asymmetric risk/reward profile perfectly aligned with our geopolitical energy theme.

SU is Canada's largest integrated energy company with direct exposure to oil price increases. With US-Iran conflict escalating at the Strait of Hormuz (20% of global oil supply), oil prices are likely to spike. SU has strong fundamentals: $15.4B Q1 revenue, $2.9B operating income, $2.1B net income, and $4.76B EBITDA. Trading at ~4.8x revenue is reasonable for integrated energy. This positions the portfolio for geopolitical tailwinds while maintaining quality.

SU is Canada's largest integrated energy company with direct exposure to oil price increases. With US-Iran conflict escalating at the Strait of Hormuz (20% of global oil supply), oil prices are likely to spike. SU has strong fundamentals: $15.4B Q1 revenue, $2.9B operating income, $2.1B net income, and $4.76B EBITDA. Trading at ~4.8x revenue is reasonable for integrated energy. This positions the portfolio for geopolitical tailwinds while maintaining quality.

SBLK faces existential risk from the Strait of Hormuz blockade threat. With Iran threatening to completely block this critical oil chokepoint and US-Iran military escalation continuing, shipping routes are at extreme risk. News reports confirm shipping traffic has dropped to 36 ships/week from 130/day pre-war. SBLK's business model depends on global trade routes, and a complete Hormuz blockade would severely impact its operations. The stock is down 2.2% to $26.69 and the geopolitical risk has moved from potential to highly probable.

GRNT faces substantial doubt about its ability to continue as a going concern with high debt maturity risk in 2027 and recent auditor change. In the current extreme geopolitical environment with Strait of Hormuz blockade likely to cause oil price volatility and credit market stress, GRNT's high leverage makes it extremely vulnerable. The stock is trading at $4.92, down 2.2% from our cost basis, and the going-concern warning represents an existential risk that violates our risk management principles.

GRNT faces substantial doubt about its ability to continue as a going concern with high debt maturity risk in 2027 and recent auditor change. In the current extreme geopolitical environment with Strait of Hormuz blockade likely to cause oil price volatility and credit market stress, GRNT's high leverage makes it extremely vulnerable. The stock is trading at $4.92, down 2.2% from our cost basis, and the going-concern warning represents an existential risk that violates our risk management principles.

GRNT presents a high-conviction energy opportunity aligned with current US-Iran geopolitical tensions. With $919K insider buying by 6 insiders at $5.36, the stock is currently trading at $4.995 (6.8% below insider purchase price), creating an attractive entry point. The company operates in oil & gas exploration with exposure to potential oil price premiums from Middle East tensions. GRNT has a low beta (0.228) and strong insider conviction, making it a defensive energy play with asymmetric upside.

RILY is currently a stub position at 4.1% of portfolio (below 5% minimum), requiring exit to eliminate monitoring cost. With +27.0% performance, exiting the full position locks in gains and generates cash for higher-conviction opportunities. The position has unknown earnings risk, making full exit the appropriate risk management action.

POOL is the largest portfolio position at 18.8% and requires risk management. With +1.4% performance and unknown earnings date, selling 1 share reduces concentration while generating cash. The cash will be redeployed to higher-conviction opportunities aligned with current geopolitical risks (energy) and sector rotation (insurance). This addresses both cash constraint and position sizing discipline.

ROCK requires thesis review and position size adjustment. Currently at 3.9% of portfolio (below 5% minimum), it's a stub position that doesn't justify monitoring cost. The $39.81 entry price is above current $37.98 price (-4.7% decline), but with strong insider buying ($1.56M by 4 insiders) and Substack $100 target (2.5x upside), the thesis remains intact. Selling 1 share reduces the position to 2 shares while maintaining exposure to the solar construction thesis.

RLI represents a high-conviction insurance sector rotation opportunity with strong fundamentals. Trading at $51.005 with Q1 2026 net income of $54.89M and $0.60 EPS, RLI shows consistent profitability in the property & casualty insurance space. With a low beta (0.383) and $4.66 dividend, it provides defensive characteristics while benefiting from sector rotation signals. The recent $859K insider buying cluster confirms management's confidence in the company's prospects.

GRNT presents a high-conviction energy opportunity aligned with current US-Iran geopolitical tensions. With $919K insider buying by 6 insiders at $5.36, the stock is currently trading at $4.995 (6.8% below insider purchase price), creating an attractive entry point. The company operates in oil & gas exploration with exposure to potential oil price premiums from Middle East tensions. GRNT has a low beta (0.228) and strong insider conviction, making it a defensive energy play with asymmetric upside.

SBLK has performed moderately well (+1.6% unrealized PnL) and is our second largest position at 17.5% of portfolio. Selling 1 share (16.7% of position) will generate approximately $27.73 in cash, increasing portfolio cash to ~13.5% and reducing concentration risk. This addresses the portfolio rebalancing imperative while maintaining exposure to this core holding.

ROCK has declined -4.1% from entry price ($39.81 to $38.16) and the Substack $100 target remains valid but distant. With 6 positions lacking formal theses and critical cash constraints, selling 1 share (50% of position) will generate $38.16 in cash, increasing portfolio cash to ~11.0% and addressing the discipline violation. This is a tactical cash generation move, not thesis invalidation, as the $100 target remains intact.

RILY has performed exceptionally well (+26.0% unrealized PnL) and represents the largest source of portfolio alpha. Selling 3 shares (42.9% of position) will generate approximately $29.31 in cash, increasing portfolio cash from 3.8% to ~7.0% and reducing concentration risk while maintaining exposure to this strong performer. This aligns with the portfolio rebalancing imperative and meets the minimum trade size requirement.

POOL has performed well (+1.4% unrealized PnL) and is our largest position at 19.0% of portfolio. Trimming 0.25 shares (25% of position) will generate approximately $44.86 in cash, increasing portfolio cash to ~10.5% and reducing concentration risk. This addresses the portfolio rebalancing imperative while maintaining exposure to this core holding.

ROCK has strong fundamentals with 12% revenue growth, margin expansion, and raised guidance. The substack $100 target represents 2.5x upside and is confirmed by the research showing sustained demand in solar and construction end-markets. We're buying 2 shares to establish a meaningful position while maintaining risk management discipline.

SBLK is our largest position at 19.6% of portfolio, exceeding our 20% maximum but violating our target of ~12.5%. We need to reduce concentration for risk management while maintaining our thesis that SBLK benefits from global trade normalization and shipping demand.

VISN is our second largest position at 18.0% of portfolio and has concerning financials with negative $1.5B net income in Q1 2026. We need to reduce concentration and address the fundamental weakness while raising cash for better opportunities.

SBLK is our largest position at 19.5% of portfolio, exceeding our 20% maximum but violating our target of ~12.5%. We need to reduce concentration for risk management while maintaining our thesis that SBLK benefits from global trade normalization and shipping demand.

VISN is trading at $12.32, well below its $14 target price from Substack. The company is a communications infrastructure provider with strong fundamentals ($471.8M revenue in Q1 2026) and benefits from the DOCSIS 4.0 upgrade tailwind. This represents an attractive entry point with asymmetric risk/reward.

RILY has performed exceptionally well (+37.7%), representing 11.0% of the portfolio. To address the portfolio's -11.0% underperformance crisis, we need to deploy capital into new opportunities like VISN and OSB. Trimming 3 shares of RILY will free up approximately $32 to fund these new positions while maintaining a meaningful RILY position.

DNA is a stub position at 4.5% of the portfolio, below the 5% minimum threshold. Stub positions below 5% do not justify monitoring cost and should be exited to free up capital for more promising opportunities. The portfolio needs optimization to address the -11.0% underperformance crisis.

ESTA has breached its stop-loss of $180.00, with current price at $71.995. The stop-loss breach triggers the default action to sell unless overwhelming new fundamental evidence is found. No such evidence has been identified in current analysis. The updated thesis indicates the FDA approval catalyst has not materialized as expected, invalidating the original investment premise.

ESTA has breached its stop-loss of $180.00, with current price at $71.995. The stop-loss breach triggers the default action to sell unless overwhelming new fundamental evidence is found. No such evidence has been identified in current analysis. The thesis has been invalidated by price action approaching the stop-loss level, and the position should be exited to preserve capital.

DNA represents healthcare/biotech exposure with potential upside from synthetic biology platform. Current valuation appears reasonable given growth potential and market divergence creates opportunity.

PLBY has a bullish Yellowbrick thesis with 120% upside to $2.90. The company is positioned to benefit from digital media trends and has a strong brand. With current cash of $51.93, buying 38 shares at $1.345 represents appropriate position sizing.